U.S. House Committee Hears Testimony Regarding Genetically Modified Mosquitoes

CQ Magazine: A British Firm’s Zika Solution Catches Congress’ Eye
“Hadyn Parry, chief executive of the British biotech company Oxitec, made a case to the House Science, Space, and Technology Committee last month that his firm can help halt the spread of the Zika virus, if only the Food and Drug Administration would let it. He said Oxitec has developed a genetically modified mosquito to interbreed with the Aedes aegypti, the mosquito breed that carries Zika, which is causing birth defects…” (Curry, 6/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.